Quantcast
Channel: Canada
Browsing latest articles
Browse All 11 View Live

Ranbaxy launches generic olanzapine tablets, in spain, on day-1 following...

Ranbaxy Laboratories Limited (Ranbaxy) today announced the Day-1 launch of Olanzapine Tablets, the generic version of Zyprexa. Ranbaxy will be introducing Olanzapine tablets 2.5mg, 5mg, 7.5mg and 10mg...

View Article



Ranbaxy UK ltd. Launches esomeprazole

Ranbaxy (UK) Ltd. announced that it has successfully launched esomeprazole 20 mg and 40 mg tablets, the first approved generic bio-equivalent version of the product NexiumTM, in the United Kingdom...

View Article

Career

View Article

Quality

View Article

Business Development

View Article


Products

View Article

DAIICHI SANKYO AND RANBAXY TO LEVERAGE SYNERGIES IN THAILAND

Daiichi Sankyo Company, Limited (Daiichi Sankyo) and Ranbaxy Laboratories Limited (Ranbaxy) today announced their intention to integrate their business operations in Thailand, to leverage and maximize...

View Article

Ranbaxy to market Desvenlafaxine Base Extended Release Tablets in The US

Enters into an in-licensing business agreement with Alembic Gurgaon, India, March 05, 2013: Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL),...

View Article


Daiichi Sankyo and Ranbaxy launch hybrid business in Brazil to expand...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Ranbaxy Laboratories Limited (hereafter, Ranbaxy) today announced synergy in Brazil to expand the business of both companies in the...

View Article


RANBAXY Response to CBS Evening News Report

Princeton, New Jersey – On November 5th and 6th, CBS Network News aired a report that focused on Ranbaxy generic medications produced in India. Unfortunately, this report conveyed broad speculation...

View Article
Browsing latest articles
Browse All 11 View Live




Latest Images